DANIELLE HUMPHREYS: Open Payments
NPI 1518937069 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 52 payments from 14 companies in 2025. Trend: 2023 $529 · 2024 $644 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $223 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $173 |
| Aimmune Therapeutics, Inc. | 9 | $152 |
| Madrigal Pharmaceuticals | 3 | $67 |
| Intercept Pharmaceuticals, Inc. | 3 | $50 |
| QOL Medical, LLC | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Gilead Sciences, Inc. | 2 | $28 |
| Ardelyx, Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
Products named: RINVOQ, XIFAXAN, ZENPEP, REZDIFFRA, OCALIVA, Sucraid, OMVOH, CREON.
Industry payments across TN — which companies pay providers there.
